CardiacWire
JANUARY 29, 2025
Researchers examined STS registry data on ~109k patients ages 40 to 75 years who received isolated bioprosthetic (94k) or mechanical (15k) AVR over 11 years and found that mechanical valve use decreased by about half (from 20% in 2008 to below 10% in 2019). They also often had lower BMI (31.0 vs 71.8%) or prior PCI (6.7 vs 23.6%).
Journal of the American Heart Association
MARCH 26, 2025
as BMI increased by category, and it prevailed more frequently among women and older people regardless of their BMI status. kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). The incidence of SMuRFlessness declined from 16.2%
Dr. Paddy Barrett
AUGUST 16, 2024
Falling into the class of obesity with a BMI of greater than 30 makes this more likely, but so also does having excess visceral fat deposition with significant metabolic consequences at a BMI less than 30. The distinction here is the metabolic consequences of excess fat causing a health risk rather than focusing on the BMI cutoff.
DAIC
JANUARY 29, 2024
Notably, MAG showed superior survival for patients with a BMI less than 40, whereas patients with a BMI of 40 or higher had superior survival with SAG.
Cardiometabolic Health Congress
JULY 25, 2023
2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2. These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5 to 25 kg/m2) and underweight (BMI less than 18.5
Dr. Paddy Barrett
MAY 24, 2024
All of these patients had a BMI >27. Type 2 diabetes is much more common in those with a BMI in the overweight or obese category but is not uncommon in those who are relatively normal weight. The answer is they were, but just not by conventional BMI standards. 2019 Dec 4;19(12):156. 2018 Feb 10;391(10120):541-551.
Dr. Paddy Barrett
NOVEMBER 15, 2024
A study of almost 10,000 adults with obesity (BMI >30) who were evaluated for all LE8 factors and followed for over 7 years can give us some insight 1. 2019 Aug 18;9(8):e029966. The answer is yes. The magnitude of that risk reduction will surprise you. Endocr Pract. 2024 Nov;30(11):1089-1096. npj Metab Health Dis 2 , 31 (2024).
Expert insights. Personalized for you.
80 
Let's personalize your content